Tehran hosted the 2nd Congress on Plasma Medicine on Thursday, bringing together leading scientists and medical experts. Notably, the event emphasized plasma medicine innovations and clinical applications. Experts highlighted how plasma medicine is transforming healthcare through new technologies and effective treatments. The two-day congress took place at Shahid Rajaei Heart Hospital. Moreover, attendees included researchers, clinicians, and industry professionals. In addition, Mohammad Eslami, Head of the Atomic Energy Organization of Iran, participated, underlining the strategic importance of plasma medicine for national healthcare development.
The conference covered a wide range of topics. For instance, preclinical studies in medical plasma, clinical applications, biomaterials, and tissue engineering were central themes. Furthermore, experts discussed device simulation and design, plasma active environments, microbial disinfection, and safety standards. Panels provided deeper insights into practical applications. One panel focused on plasma medicine in wound healing, while another examined its effects on microorganisms. In addition, attendees explored plasma applications in cancer treatment and laboratory-based plasma research. Meanwhile, discussions included engineering perspectives and regulatory frameworks, underlining the need for safety and standardization.
Officials noted that plasma medicine offers substantial potential for improving patient outcomes. Specifically, Eslami explained that integrating plasma technologies in hospitals could enhance treatment efficiency and reduce infection risks. Moreover, scientists at the congress shared recent data showing accelerated healing and antimicrobial effects of plasma applications. Industry representatives emphasized collaboration between research institutions and hospitals. They argued that investment in plasma medicine could foster innovation, attract talent, and strengthen Iran’s position in global medical research. Additionally, researchers noted the importance of continued preclinical studies to ensure safety and efficacy.
The congress also highlighted the growing role of technology in medicine. For example, advancements in plasma device design and simulation promise more precise and effective treatments. Consequently, attendees discussed how interdisciplinary approaches could expand plasma medicine into broader clinical applications, including oncology and tissue engineering. Experts forecast significant growth in the plasma medicine sector.
They stressed that ongoing research, policy support, and international collaboration would be crucial. Therefore, the next steps involve clinical trials, regulatory approvals, and wider adoption in healthcare facilities. The Tehran congress demonstrated Iran’s commitment to scientific innovation. By bringing together experts, regulators, and industry leaders, the event reinforced the potential of plasma medicine to transform medical practice.